Evidence map›Paper›PMID 21740400›Full record

ReviewASN neuro2011

Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model.

Valerie L Jacobs, Pablo A Valdes, William F Hickey, Joyce A De Leo

Abstract readReview
In one paragraph

Review in ASN neuro, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed.

  1. Article
  2. Article
  3. Hydrogel Microdroplet Based Glioblastoma Drug Screening Platform.Journal of biomedical materials research. Part A · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. The first endovascular rat glioma model for pre-clinical evaluation of intra-arterial therapeutics.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Valerie L JacobsDepartment of Pathology, Dartmouth Medical School, Lebanon, NH 03756, U.S.A. Valerie.L.Jacobs@dartmouth.edu
Pablo A Valdes
William F Hickey
Joyce A De Leo

Funding

Cannabinoids and Neuroimmune InteractionsR01DA025211 · NIDA · DARTMOUTH COLLEGE · PI ROMERO-SANDOVAL, E. ALFONSO · 2009 to 2010
$711k
NIDA NIH HHS 1R01DA025211NIDA NIH HHS R01 DA025211PHS HHS T32 A107363
6 · The paper itself

Abstract

GBM (glioblastoma multiforme) is a highly aggressive brain tumour with very poor prognosis despite multi-modalities of treatment. Furthermore, recent failure of targeted therapy for these tumours highlights the need of appropriate rodent models for preclinical studies. In this review, we highlight the most commonly used rodent models (U251, U86, GL261, C6, 9L and CNS-1) with a focus on the pathological and genetic similarities to the human disease. We end with a comprehensive review of the CNS-1 rodent model.

Indexed as

Disease Models, AnimalAnimalsBrain NeoplasmsCell Line, TumorClinical Trials as TopicGlioblastomaHumans

Identifiers

PMID21740400
PMCPMC3153964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.